CHIP, Department of Infectious Diseases, Section 2100

Copenhagen 2100

0 studies enrolling now · 2 studies all time

What they study most

COVID, COVID-19, Clostridium Difficile, SARS (Severe Acute Respiratory Syndrome), SARS-CoV-2

Studies at this site

• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) — Completed
• Observational Study of C. Diff in Post-Transplant Patients — Completed